Regulatory claims made by US businesses engaged in direct-to-consumer marketing of purported stem cell treatments and exosome therapies
出版年份 2023 全文链接
标题
Regulatory claims made by US businesses engaged in direct-to-consumer marketing of purported stem cell treatments and exosome therapies
作者
关键词
-
出版物
Regenerative Medicine
Volume -, Issue -, Pages -
出版商
Future Medicine Ltd
发表日期
2023-10-23
DOI
10.2217/rme-2023-0117
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Online marketing practices of regenerative medicine clinics in US-Mexico border region: a web surveillance study
- (2021) Javier Chavez et al. Stem Cell Research & Therapy
- International stem cell tourism: a critical literature review and evidence-based recommendations
- (2021) Samantha Lyons et al. International Health
- Unproven stem cell interventions: A global public health problem requiring global deliberation
- (2021) Zubin Master et al. Stem Cell Reports
- The American stem cell sell in 2021: U.S. businesses selling unlicensed and unproven stem cell interventions
- (2021) Leigh Turner Cell Stem Cell
- Adverse events related to unapproved stem cell products and other regenerative interventions: recommendations for more robust regulation of the direct-to-consumer marketplace
- (2021) Farzana Akkas et al. Regenerative Medicine
- Online seminars as an information source for direct-to-consumer stem cell therapy
- (2021) Mirna Hassoun et al. Regenerative Medicine
- Stem-cell clinics in the UK: a web-based study
- (2021) Sami Kamel et al. Regenerative Medicine
- Cell-based therapies for retinal diseases: a review of clinical trials and direct to consumer “cell therapy” clinics
- (2021) John W. Hinkle et al. Stem Cell Research & Therapy
- Weighing up the evidence used by direct-to-consumer stem cell businesses
- (2021) Margaret Cook et al. Stem Cell Reports
- Investigation of Bacterial Infections Among Patients Treated With Umbilical Cord Blood–Derived Products Marketed as Stem Cell Therapies
- (2021) Kathleen P. Hartnett et al. JAMA Network Open
- Clear Evidence of Safety and Efficacy Is Needed for Stromal Vascular Fraction Products: Commentary on “Arguments for a Different Regulatory Categorization and Framework for Stromal Vascular Fraction”
- (2020) Peter W. Marks STEM CELLS AND DEVELOPMENT
- Rogue stem cell clinics
- (2020) Iain R. Murray et al. Bone & Joint Journal
- Governmental Regulations and Increasing FDA Oversight of Regenerative Medicine Products: What's New in 2020?
- (2020) William Fang et al. ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY
- Assessing “cell therapy” clinics offering treatments of ocular conditions using direct-to-consumer marketing websites in the United States
- (2019) Rajinder S. Nirwan et al. OPHTHALMOLOGY
- Rapid change of a cohort of 570 unproven stem cell clinics in the USA over 3 years
- (2019) Paul S Knoepfler Regenerative Medicine
- Characterizing Direct-to-Consumer Stem Cell Businesses in the Southwest United States
- (2019) Emma K. Frow et al. Stem Cell Reports
- Direct-to-Consumer Advertising of Stem Cell Clinics
- (2019) Christian A. Pean et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Online Direct-to-Consumer Advertising of Stem Cell Therapy for Musculoskeletal Injury and Disease
- (2019) Matthew T. Kingery et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- The FDA and the US direct-to-consumer marketplace for stem cell interventions: a temporal analysis
- (2018) Paul S Knoepfler et al. Regenerative Medicine
- Exploiting science? A systematic analysis of complementary and alternative medicine clinic websites’ marketing of stem cell therapies
- (2018) Blake Murdoch et al. BMJ Open
- Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions
- (2018) Gerhard Bauer et al. Stem Cells Translational Medicine
- Unproven Stem Cell Therapies in India: Regulatory Challenges and Proposed Paths Forward
- (2018) Shashank S. Tiwari et al. Cell Stem Cell
- The deadly business of an unregulated global stem cell industry
- (2017) Tamra Lysaght et al. JOURNAL OF MEDICAL ETHICS
- Vision Loss after Intravitreal Injection of Autologous “Stem Cells” for AMD
- (2017) Ajay E. Kuriyan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Getting Products to Market: Understanding and Navigating the Regulatory Pathway
- (2017) Andrew J. Riff et al. OPERATIVE TECHNIQUES IN SPORTS MEDICINE
- Stem cells in court: historical trends in US legal cases related to stem cells
- (2017) Andreia Martins Martinho et al. Regenerative Medicine
- Marketing of unproven stem cell–based interventions: A call to action
- (2017) Douglas Sipp et al. Science Translational Medicine
- The Stem-Cell Market for the Treatment of Knee Osteoarthritis: A Patient Perspective
- (2017) Mitchell Ng et al. Journal of Knee Surgery
- Bilateral Retinal Detachments After Intravitreal Injection of Adipose-Derived ‘Stem Cells’ in a Patient With Exudative Macular Degeneration
- (2017) Steven S. Saraf et al. Ophthalmic Surgery Lasers & Imaging Retina
- Global Distribution of Businesses Marketing Stem Cell-Based Interventions
- (2016) Israel Berger et al. Cell Stem Cell
- Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry
- (2016) Leigh Turner et al. Cell Stem Cell
- The Stem Cell Hard Sell: Report from a Clinic's Patient Recruitment Seminar
- (2016) Paul S. Knoepfler Stem Cells Translational Medicine
- Complication of Autologous Stem Cell Transplantation in Retinitis Pigmentosa
- (2016) Katherine Boudreault et al. JAMA Ophthalmology
- Retinal Detachment After Subretinal Stem Cell Transplantation
- (2016) Ella H. Leung et al. Ophthalmic Surgery Lasers & Imaging Retina
- From bench to FDA to bedside: US regulatory trends for new stem cell therapies
- (2015) Paul S. Knoepfler ADVANCED DRUG DELIVERY REVIEWS
- US clinics marketing unproven and unlicensed adipose-derived autologous stem cell interventions
- (2015) Leigh G Turner Regenerative Medicine
- Concise Review: The U.S. Food and Drug Administration and Regenerative Medicine
- (2015) Celia M. Witten et al. Stem Cells Translational Medicine
- Governing stem cell therapy in India: regulatory vacuum or jurisdictional ambiguity?
- (2014) Shashank S. Tiwari et al. NEW GENETICS AND SOCIETY
- Representations of Stem Cell Clinics on Twitter
- (2014) Kalina Kamenova et al. Stem Cell Reviews and Reports
- Stem cell tourism – A web-based analysis of clinical services available to international travellers
- (2014) Ruairi Connolly et al. Travel Medicine and Infectious Disease
- Reassessing direct-to-consumer portrayals of unproven stem cell therapies: is it getting better?
- (2013) Ubaka Ogbogu et al. Regenerative Medicine
- Direct-to-Consumer Stem Cell Marketing and Regulatory Responses
- (2013) Douglas Sipp Stem Cells Translational Medicine
- China’s stem-cell rules go unheeded
- (2012) David Cyranoski NATURE
- The unregulated commercialization of stem cell treatments: a global perspective
- (2011) Douglas Sipp Frontiers of Medicine
- Tracking the rise of stem cell tourism
- (2009) Kirsten A Ryan et al. Regenerative Medicine
- MEDICINE: Monitoring and Regulating Offshore Stem Cell Clinics
- (2009) S. Kiatpongsan et al. SCIENCE
- Medicine on the Fringe: Stem Cell-Based Interventions in Advance of Evidence
- (2009) Alan C. Regenberg et al. STEM CELLS
- Stem Cell Clinics Online: The Direct-to-Consumer Portrayal of Stem Cell Medicine
- (2008) Darren Lau et al. Cell Stem Cell
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started